Recombinant multi-species VIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VIP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the glucagon family. It stimulates myocardial contractility, causes vasodilation, increases glycogenolysis, lowers arterial blood pressure and relaxes the smooth muscle of trachea, stomach and gall bladder. The protein also acts as an antimicrobial peptide with antibacterial and antifungal activity. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Nov 2014]
The Alternative Names of target: PHM27,VIP,VIP peptides,Vip,vip/phi27
Go
to VIP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T88213-Ag-1/ GM-Tg-hg-T88213-Ag-2 | Human VIP protein | Human |
| GM-Tg-rg-T88213-Ag-1/ GM-Tg-rg-T88213-Ag-2 | Rat VIP protein | Rat |
| GM-Tg-mg-T88213-Ag-1/ GM-Tg-mg-T88213-Ag-2 | Mouse VIP protein | Mouse |
| GM-Tg-cynog-T88213-Ag-1/ GM-Tg-cynog-T88213-Ag-2 | Cynomolgus/Rhesus macaque VIP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T88213-Ag-1/ GM-Tg-felg-T88213-Ag-2 | Feline VIP protein | Feline |
| GM-Tg-cang-T88213-Ag-1/ GM-Tg-cang-T88213-Ag-2 | Canine VIP protein | Canine |
| GM-Tg-bovg-T88213-Ag-1/ GM-Tg-bovg-T88213-Ag-2 | Bovine VIP protein | Bovine |
| GM-Tg-equg-T88213-Ag-1/ GM-Tg-equg-T88213-Ag-2 | Equine VIP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T88213-Ag-1/ GM-Tg-hg-T88213-Ag-2;
GM-Tg-rg-T88213-Ag-1/ GM-Tg-rg-T88213-Ag-2;
GM-Tg-mg-T88213-Ag-1/ GM-Tg-mg-T88213-Ag-2; GM-Tg-cynog-T88213-Ag-1/ GM-Tg-cynog-T88213-Ag-2; GM-Tg-felg-T88213-Ag-1/ GM-Tg-felg-T88213-Ag-2; GM-Tg-cang-T88213-Ag-1/ GM-Tg-cang-T88213-Ag-2; GM-Tg-bovg-T88213-Ag-1/ GM-Tg-bovg-T88213-Ag-2; GM-Tg-equg-T88213-Ag-1/ GM-Tg-equg-T88213-Ag-2 |
| Products Name | VIP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | VIP |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VIP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.